Detalhe da pesquisa
1.
Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.
Parasitol Res
; 120(1): 321-335, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33191446
2.
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Exp Parasitol
; 199: 30-37, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817917
3.
In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.
J Mol Graph Model
; 87: 89-97, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522092
4.
A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
Parasitol Int
; 73: 101966, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362122
5.
Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.
PLoS Negl Trop Dis
; 6(1): e1430, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22272364
6.
Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.
Clin Vaccine Immunol
; 16(12): 1774-80, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19812259